NCT04474366View on ClinicalTrials.gov

The Effect of Pectoral Blocks on Perioperative Pain in Gender Affirmation Top Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 16, 2020

Primary Completion Date

February 28, 2022

Study Completion Date

April 30, 2022

Conditions
Gender DysphoriaOpioid UsePain, Postoperative
Interventions
DRUG

Ropivacaine 0.2% Injectable Solution

Ropivacaine 0.2% Injectable Solution injected as part of the Pectoralis Nerve Block

OTHER

Saline (0.9%)

Saline injection as sham block in identical fashion as Pectoralis Nerve Block

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT04474366 - The Effect of Pectoral Blocks on Perioperative Pain in Gender Affirmation Top Surgery | Biotech Hunter | Biotech Hunter